Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bacitracin + xeroform
- Development stage
- Unknown
- Modality
- Peptides, Small Molecules
- Administration
- Topical
01
Overview
A combination treatment approach using bacitracin topical antibiotic ointment with Xeroform petrolatum gauze dressing. Bacitracin is an antibiotic that prevents bacterial infections by inhibiting bacterial cell wall synthesis, while Xeroform is a non-adherent dressing containing 3% bismuth tribromophenate with bacteriostatic properties. This combination is commonly used for partial thickness burns, skin grafts, and minor skin injuries, particularly in pediatric patients.
- Brand names
- XeroformBacitracin
- Other names
- antibiotic-Southern Illinois Universityantibiotic burn dressingXeroform/Bacitracin
02
Targets
C55-PP (Undecaprenyl pyrophosphate)
Beyond the preview
Go deeper on bacitracin + xeroform.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bacitracin + xeroform.